What is Insulin (regular human)?
The 51-amino-acid pancreatic hormone that lowers blood glucose; this page covers regular (short-acting) insulin studied in human trials.
Insulin (regular human) in the library · · Human Trials · What are peptides?
440 registered trials · 305 indexed papers · 6750 human / 1745 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What it is
The 51-amino-acid pancreatic hormone that lowers blood glucose; this page covers regular (short-acting) insulin studied in human trials.
Type: Peptide hormone.
Definition (National Library of Medicine)
“A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (glycogenolysis; gluconeogenesis) and indirectly by suppressing glucagon secretion and lipolysis. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (diabetes mellitus, type 1).”
- MeSH: Insulin
Human research
The registered human trials and peer-reviewed human studies linked below are listed from ClinicalTrials.gov and PubMed. A study is linked only when Insulin (regular human) is one of its interventions, or is named in the study title or subject headings.
Listing a study does not mean it showed a benefit, and it is not medical advice.
Registered human trials (440)
Peer-reviewed studies (305)
More cited research
- Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience (2026, human case report)
- GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study (2026, human observational)
- Long-term remission of type B insulin resistance syndrome with immunotherapy: A case report (2026, human case report)
- Recombinant human insulin-like growth factor 1 complex preserves lung development in mechanically ventilated preterm lambs (2026, human observational)
- Kisspeptin improves local ovarian insulin resistance in PCOS by modulating the PI3K/AKT/GLUT4 signaling pathway (2026, animal)
- Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001 (2025, animal)
- Existence of Coexpressive Role of Kisspeptin and Insulin-2 in the Regulation of Luteinizing Hormone in Chronic Stress-Induced Polycystic Ovarian Syndrome-Like P (2025, animal)
- GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway (2025, animal)
Conditions researched
- Anti-aging & longevity
- Atherosclerosis, cardiovascular disease & high blood pressure
- Chronic and systemic inflammation
- Delayed gastric emptying on GLP-1 medicines
- Dementia, Alzheimer's & cognitive decline
- Fat loss, obesity & body recomposition
- Fatty liver & elevated liver enzymes
- Gallbladder and gallstones
- Hashimoto's (autoimmune thyroid)
- Heart repair: after heart attack, heart failure & enlarged heart
- Herpes (HSV) and cold sores
- High cholesterol and statins
- High ferritin and iron overload
- Insulin resistance, prediabetes & type 2 diabetes
- Lipomas
- Lupus (SLE)
- Lymphedema and swelling
- Menopause & perimenopause
- Menstrual cramps (dysmenorrhea)
- Migraine
- Mitochondrial dysfunction
- Multiple sclerosis
- PCOS
- Sleep apnea (obstructive)
- Acne
- Carpal tunnel
- Cognition, focus & brain performance
- Concussion, traumatic brain injury & stroke recovery
- Diabetic retinopathy and glaucoma
- Eyes: macular degeneration & retinal health
- Female fertility
- Gum disease (periodontal) & oral health
- Immune system (general)
- Kidney protection (CKD, diabetic kidney, lupus kidney)
- Low blood pressure and orthostatic hypotension
- Lung health, asthma & COPD
- Muscle gain, sarcopenia & building muscle after 40
- Osteoporosis and bone density
- Pancreatitis (after the acute phase)
- Parkinson's disease
- Post-surgical inflammation and surgery recovery
- Pregnancy and breastfeeding: safety notes
- Sexual function & libido (women and men)
- Skin, hair loss, wounds & mast-cell/histamine reactivity
- Sleep problems (incl. insomnia on peptides)
Related compounds
- Glutathione
- ACTH (Corticotropin)
- L-Carnitine
- Vasopressin
- Cyanocobalamin (Vitamin B12)
- Semaglutide
- IGF-1 LR3
- Oxytocin
- Liraglutide
- Parathyroid Hormone (PTH 1-84)
FAQ
What is Insulin (regular human)?
The 51-amino-acid pancreatic hormone that lowers blood glucose; this page covers regular (short-acting) insulin studied in human trials.
How many registered human trials study Insulin (regular human)?
The PeptideWhiz trial index lists 440 registered trials for Insulin (regular human), the most recent from 2027.
How much published research exists on Insulin (regular human)?
The PeptideWhiz paper index links 305 PubMed papers to Insulin (regular human); by study type, 6750 human and 1745 animal studies.
Which conditions is Insulin (regular human) researched for?
Anti-aging & longevity, Atherosclerosis, cardiovascular disease & high blood pressure, Chronic and systemic inflammation, Delayed gastric emptying on GLP-1 medicines, Dementia, Alzheimer's & cognitive decline, Fat loss, obesity & body recomposition, Fatty liver & elevated liver enzymes, Gallbladder and gallstones, Hashimoto's (autoimmune thyroid), Heart repair: after heart attack, heart failure & enlarged heart, Herpes (HSV) and cold sores, High cholesterol and statins, High ferritin and iron overload, Insulin resistance, prediabetes & type 2 diabetes, Lipomas, Lupus (SLE), Lymphedema and swelling, Menopause & perimenopause, Menstrual cramps (dysmenorrhea), Migraine, Mitochondrial dysfunction, Multiple sclerosis, PCOS, Sleep apnea (obstructive), Acne, Carpal tunnel, Cognition, focus & brain performance, Concussion, traumatic brain injury & stroke recovery, Diabetic retinopathy and glaucoma, Eyes: macular degeneration & retinal health, Female fertility, Gum disease (periodontal) & oral health, Immune system (general), Kidney protection (CKD, diabetic kidney, lupus kidney), Low blood pressure and orthostatic hypotension, Lung health, asthma & COPD, Muscle gain, sarcopenia & building muscle after 40, Osteoporosis and bone density, Pancreatitis (after the acute phase), Parkinson's disease, Post-surgical inflammation and surgery recovery, Pregnancy and breastfeeding: safety notes, Sexual function & libido (women and men), Skin, hair loss, wounds & mast-cell/histamine reactivity, Sleep problems (incl. insomnia on peptides).
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).